Loading...
Serostatus testing and dengue vaccine cost–benefit thresholds
The World Health Organization (WHO) currently recommends pre-screening for past infection prior to administration of the only licensed dengue vaccine, CYD-TDV. Using a threshold modelling analysis, we identify settings where this guidance prohibits positive net-benefits, and are thus unfavourable. G...
Na minha lista:
| Udgivet i: | J R Soc Interface |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The Royal Society
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6731500/ https://ncbi.nlm.nih.gov/pubmed/31431184 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1098/rsif.2019.0234 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|